Litcius/Paper detail

Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis

Jatinder Kumar, Seyed Behzad Jazayeri, Shiva Gautam, Daniel Norez, Muhammad Umar Alam, Karthik Tanneru, Soroush Bazargani, Joseph Costa, Mark Bandyk, Hariharan Palayapalayam Ganapathi, Shahriar Koochekpour, K.C. Balaji

2020Urologic Oncology Seminars and Original Investigations33 citationsDOI

Topics & Concepts

EnzalutamideMedicineProstate cancerHazard ratioInternal medicineMeta-analysisConfidence intervalAdverse effectOncologyCancerAndrogen receptorProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment
Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis | Litcius